178 related articles for article (PubMed ID: 38655365)
1. Pan-cancer analysis of SLC2A family genes as prognostic biomarkers and therapeutic targets.
Liu Y; Li X; Yang J; Chen S; Zhu C; Shi Y; Dang S; Zhang W; Li W
Heliyon; 2024 Apr; 10(8):e29655. PubMed ID: 38655365
[TBL] [Abstract][Full Text] [Related]
2.
Zhang Y; Qin H; Bian J; Ma Z; Yi H
Front Pharmacol; 2022; 13():1045179. PubMed ID: 36518662
[TBL] [Abstract][Full Text] [Related]
3. Pan-cancer analysis reveals the characteristics and roles of tooth agenesis mutant genes.
Liu Y; Yang J; Li X; Chen S; Zhu C; Shi Y; Dang S; Zhang W; Li W
Medicine (Baltimore); 2023 Dec; 102(50):e36001. PubMed ID: 38115305
[TBL] [Abstract][Full Text] [Related]
4. SLC2A2 (GLUT2) as a novel prognostic factor for hepatocellular carcinoma.
Kim YH; Jeong DC; Pak K; Han ME; Kim JY; Liangwen L; Kim HJ; Kim TW; Kim TH; Hyun DW; Oh SO
Oncotarget; 2017 Sep; 8(40):68381-68392. PubMed ID: 28978124
[TBL] [Abstract][Full Text] [Related]
5. Pan-cancer analysis of SERPINE family genes as biomarkers of cancer prognosis and response to therapy.
Liu Y; Li X; Chen S; Zhu C; Shi Y; Dang S; Zhang W; Li W
Front Mol Biosci; 2023; 10():1277508. PubMed ID: 38274096
[No Abstract] [Full Text] [Related]
6. Multiple facilitated glucose transporters SLC2As are required for normal mouse preimplantation embryo development.
Arhin SK; Zhao J; Ji X; Shi C; Tang J; Gu Y; Xi H; Cheng J; Qu X; Shi H; Jin X; Lv J
Am J Transl Res; 2019; 11(6):3412-3425. PubMed ID: 31312354
[TBL] [Abstract][Full Text] [Related]
7. Solute carrier family 2 members 1 and 2 as prognostic biomarkers in hepatocellular carcinoma associated with immune infiltration.
Peng Q; Hao LY; Guo YL; Zhang ZQ; Ji JM; Xue Y; Liu YW; Lu JL; Li CG; Shi XL
World J Clin Cases; 2022 May; 10(13):3989-4019. PubMed ID: 35665115
[TBL] [Abstract][Full Text] [Related]
8. Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy.
Zheng H; Long G; Zheng Y; Yang X; Cai W; He S; Qin X; Liao H
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358765
[TBL] [Abstract][Full Text] [Related]
9. A pan-cancer analysis of the HER family gene and their association with prognosis, tumor microenvironment, and therapeutic targets.
Yang X; Miao Y; Wang J; Mi D
Life Sci; 2021 May; 273():119307. PubMed ID: 33691171
[TBL] [Abstract][Full Text] [Related]
10. Pan-cancer evidence of prognosis, immune infiltration, and immunotherapy efficacy for annexin family using multi-omics data.
Shen C; Zhang S; Zhang Z; Yang S; Zhang Y; Lin Y; Fu C; Li Z; Wu Z; Wang Z; Li Z; Guo J; Li P; Hu H
Funct Integr Genomics; 2023 Jun; 23(3):211. PubMed ID: 37358720
[TBL] [Abstract][Full Text] [Related]
11. Pan-Cancer Analysis of the TRP Family, Especially TRPV4 and TRPC4, and Its Expression Correlated with Prognosis, Tumor Microenvironment, and Treatment Sensitivity.
Chen Z; Zhao Y; Tian Y; Cao R; Shang D
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830651
[TBL] [Abstract][Full Text] [Related]
12. TMX family genes and their association with prognosis, immune infiltration, and chemotherapy in human pan-cancer.
Luo N; Mei Z; Zhang Q; Tang H; Wan R; Deng A; Zou X; Lv C
Aging (Albany NY); 2023 Dec; 15(24):15064-15083. PubMed ID: 38147024
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive pan-cancer analysis: essential role of ABCB family genes in cancer.
Xiao HN; Zhao ZY; Li JP; Li AY
Transl Cancer Res; 2024 Apr; 13(4):1642-1664. PubMed ID: 38737683
[TBL] [Abstract][Full Text] [Related]
14. A Pan-Cancer Analysis of the BIRC Gene Family and Its Association with Prognosis, Tumor Microenvironment, and Therapeutic Targets.
Wu S; Zang Q; Xing Z; Li X; Leng J; Liu Y; Wang X; Yang J
Crit Rev Eukaryot Gene Expr; 2021; 31(4):35-48. PubMed ID: 34587434
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
[TBL] [Abstract][Full Text] [Related]
16. Expressions of glucose transporter genes are diversely attenuated and significantly associated with prostate cancer progression.
Huang H; Song S; Liu W; Ye S; Bao Y; Mirza M; Li B; Huang J; Zhu R; Lian H
Am J Clin Exp Urol; 2023; 11(6):578-593. PubMed ID: 38148933
[TBL] [Abstract][Full Text] [Related]
17. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
Huang S; Sun L; Hou P; Liu K; Wu J
Front Immunol; 2022; 13():944898. PubMed ID: 36148220
[TBL] [Abstract][Full Text] [Related]
18. A pan-cancer analysis to determine the prognostic analysis and immune infiltration of HSPA5.
Zhu RK; Zhang W; Zhang YX; Hui Z; Wang XW
Curr Cancer Drug Targets; 2023 May; ():. PubMed ID: 37157205
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity.
Liu T; Yang K; Chen J; Qi L; Zhou X; Wang P
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830695
[TBL] [Abstract][Full Text] [Related]
20. Pan-cancer analysis reveals interleukin-17 family members as biomarkers in the prediction for immune checkpoint inhibitor curative effect.
Han X; Ye J; Huang R; Li Y; Liu J; Meng T; Song D
Front Immunol; 2022; 13():900273. PubMed ID: 36159856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
